DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Pemovska T, Johnson E, Kontro M, Repasky GA, Chen J, Wells P. et al.
Axitinib effectively inhibits BCR-ABL1(T315I) with a distinct binding conformation.
Nature 2015;
519: 102-5
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.